Previous studies have shown that women (W) undergoing coronary revascularization (CR) have a higher incidence of in-hospital complications than men (M). To determine whether W have an unfavorable long-term outcome after percutaneous (PCI) or surgical (CABG) CR compared with M, we evaluated patients (pts) enrolled within the Arterial Revascularization Therapies Study (ARTS). Methods: We prospectively evaluated 1205 pts with angina or silent ischemia and multivessel (MV) disease randomized to PCI or CABG of whom 283 (23%) were W. The clinical presentation, in-hospital complications and the freedom from major adverse cardiac and cerebrovascular events at 3-years were evaluated. Results: W were older (65 vs 59 years), with a higher prevalence of hypertension (59% vs 40%, p(less)0.001), hypercholestelolemia (71% vs 54%, p(less)0.001), family history for coronary artery disease (52% vs 37%, p(less)0.001) and stable angina (64% vs 57%, p=0.03) than M, but had a lower incidence of history of myocardial infarction (35% vs 46%, p(less)0.001) or current smoking (18% vs 30%, p(less)0.001). The presence of unstable angina, the extent of coronary artery disease and the location of the stenosis was similar in W and M. W assigned to CABG received the same number of arterial conduits and had similar number of distal anastomoses compared to M (2.5+0.7 vs 2.5+0.7 and 2.6+1.0 vs 2.8+1.1 respectively, p:ns). A higher incidence of in-hospital death (3.2% vs 0.5%, p=0.001) and major bleeding complications (4.2% vs 1.5%, p=0.01) were observed in W compared to M, because of increased mortality in W post-CABG (CABG=4.1%, PCI=2.17%) and bleeding events following PCI (PCI=7.2%, CABG=1.38%). At an average of 3 years follow-up the survival without death / cerebrovascular accident / myocardial infarction / revascularization was similar in M and W. (M : PCI=66.2%, CABG=83.9% ; W : PCI = 64.5%, CABG=81.4%). Conclusion:The 3 year outcomes of W with MV disease undergoing CR are similar to those in M. Despite the similarity in long-term outcomes, there are several gender-specific differences in clinical characteristics and risk factors profile resulting in higher in-hospital complications in W.
Background: Over the last several years, the number of PCI in acute myocardial infarction (AMI) has increased and stent has become an established gold standard with increased use of Gp2b3a inhibitors as an adjunctive therapy and facilitated PCI is being currently evaluated. The objectives of this study is to assess the evolution and trends of PCI in AMI over the last eight years from a single center prospective registry. Methods: Our registry started in January 1995 with pre defined strategy in AMI < 12 hours: no contra-indication regarding pre-hospital thrombolysis, direct admission in the cathlab for immediate coronary angiogram, angioplasty when indicated and stent when feasible. Results: From 1995 to 2002, a total of 1824 consecutive patients underwent PCI in AMI. They were 61.8+14.4 years, 78% males, 17% diabetes mellitus, 12% previous MI, 45% anterior MI and 13% in cardiogenic shock. Evolution is summarized below. Background. Currently available randomized trials on primary stenting for ST-segment elevation myocardial infarction (STEMI), have enrolled highly selected patients, after the initial angiogram. In the Zwolle 6 randomized trial, 1683 patients with STEMI were randomized, before angiography, to stent (S) or balloon (B), without any exclusion criteria. In this study we present data from the subanalysis conducted in diabetic patients. Methods. Among a total of 1683 consecutive patients with STEMI enrolled in the study, 177 (10.5%) suffered from diabetes (S = 94 and B = 83). The primary endpoint was MACE (death, reinfarction, and/or reintervention at 1-year).
Conclusion
Results. The cross-over rates from B to S and S to B were 30.3% and 20.2%, respectively. No difference was observed in 1-year mortality and MACE according to intentionto-treat analysis (see figure) . Conclusions. Our study is the first randomized trial comparing stenting and balloon angioplasty in a large cohort of unselected, consecutive patients. This subanalysis showed that routine stenting does not improve clinical outcome in diabetic patients undergoing primary angioplasty for STEMI.
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Long-Term (Seven-Year) Outcomes After Bare Metal Coronary Stenting for Unprotected Left Main Coronary Stenosis
Shinichi Shirai, Kenji Ando, Kei Nishiyama, Takashi Yamada, Jiro Ando, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi, Kokura Memorial Hospital, Kitakyushu, Japan
Background) Drug eluting stent may spread the indication of coronary intervention. Therefore, the longer-term efficacy of bare metal coronary stenting for unprotected left main coronary artery (LMCA) stenosis is necessary to be evaluated. Methods) Between March 1991 and August 1996, 36 consecutive patients (pts) with unprotected LMCA stenosis underwent elective stenting. Treated pts were divided into 2 groups; good candidate group (GC:17pts) for coronary artery bypass grafting(CABG), and poor candidate group (PC 19pts) with risk factors; old age (>75 yrs) in 8pts, cerebrovascular disease in 7 pts, prior CABG in 5 pts, poor LV (ejection fraction<40%) in 2 pts, COPD in 1 patient (pt), cancer in 1 pt, and poor run off in 1 pt. Clinical follow-up was performed with mean interval of 64±36 months.
Results) The procedure success rate was 100%. 3-6month angiographic follow-up was performed in 34 pts, and the restenosis rate was 21% (7/34). During the follow-up period, thirteen pts were died (3 cardiac, 10 noncardiac Repeat PTCA (%) 7.0 2.9 2 2.4
In hospital Death (%) 13 10 8 8
